Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01144780

Enrollment

Registered

2010-06-16

Start date

2009-09-30

Completion date

2012-06-30

Last updated

2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)

Brief summary

The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).

Exclusion criteria

Any patient who is not willing to give consent.

Countries

United States

Outcome results